Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 12-1997 | |
| Assets | ||
| Current Assets | ||
| Other current assets | 3,400 | 690 |
| TOTAL | $3,400 | $690 |
| Non-Current Assets | ||
| Other Non-Current Assets | 220 | 220 |
| TOTAL | $220 | $220 |
| Total Assets | $3,620 | $910 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 2,810 |
| Accounts payable and accrued liabilities | 8,600 | 2,230 |
| Accrued Expenses | 5,270 | 2,570 |
| Other current liabilities | 0 | 2,090 |
| TOTAL | $13,890 | $9,760 |
| Non-Current Liabilities | ||
| TOTAL | $130 | $160 |
| Total Liabilities | $14,020 | $9,920 |
| Shareholders' Equity | ||
| Common Shares | 10 | 450 |
| Other shareholders' equity | -2,200 | -270 |
| TOTAL | $112,400 | $180 |
| Total Liabilities And Equity | $126,420 | $10,100 |